MPP: BLOCK 2: LOWERY : SKELETAL/BONE PHYS. & PHARM. (PART 4 OF 4)
24 Questions
5 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the primary mechanism of action of romosozumab?

  • Increasing bone resorption rate
  • Reducing inhibition of the Wnt pathway (correct)
  • Targeting RANKL to reduce osteoclastogenesis
  • Inhibiting osteoclast activity
  • Which of the following therapies is recommended after a one-year course of teriparatide?

  • Switch to calcium and vitamin D supplementation
  • Use another anabolic agent without interruption
  • Continue teriparatide indefinitely
  • Start an anti-resorptive therapy (correct)
  • What is the primary risk associated with the use of romosozumab?

  • Development of atypical femoral fractures
  • Chronic kidney disease development
  • Increased risk of myocardial infarction and stroke (correct)
  • Overactive osteoblast function leading to fractures
  • Which cell type is primarily inhibited by bisphosphonates, such as alendronate?

    <p>Osteoclasts</p> Signup and view all the answers

    For which situation is teriparatide primarily recommended?

    <p>When bisphosphonates have failed</p> Signup and view all the answers

    Which of the following therapies is classified as anti-resorptive?

    <p>Denosumab</p> Signup and view all the answers

    What is the role of calcium and vitamin D in osteoporosis management?

    <p>They are recommended for patients with insufficient dietary intake</p> Signup and view all the answers

    When should a drug holiday be considered for bisphosphonate therapy?

    <p>Due to the risk of atypical femoral fractures and ONJ</p> Signup and view all the answers

    What is the primary mechanism of action of teriparatide?

    <p>Activates osteoblasts to increase bone formation</p> Signup and view all the answers

    How do anti-resorptive drugs stabilize bone mass?

    <p>By reducing resorption</p> Signup and view all the answers

    Which anabolic therapy requires monthly subcutaneous injections?

    <p>Romosozumab</p> Signup and view all the answers

    Which statement about teriparatide and osteosarcoma is accurate?

    <p>The black box warning was removed, allowing longer duration for high-risk patients.</p> Signup and view all the answers

    What should be done with a patient after two years on teriparatide who has gained BMD?

    <p>Consider anti-resorptive therapy</p> Signup and view all the answers

    What condition is teriparatide primarily recommended for?

    <p>Very low BMD or high fracture risk</p> Signup and view all the answers

    Which of the following is a consequence of sustained PTH signaling?

    <p>Promotion of osteoclastogenesis</p> Signup and view all the answers

    Which therapy is the preferred option when bisphosphonates have failed?

    <p>Teriparatide</p> Signup and view all the answers

    What is the major function of osteoblasts in bone formation?

    <p>Secrete bone matrix</p> Signup and view all the answers

    Which of the following correctly describes the activity of osteoclasts?

    <p>They degrade bone matrix</p> Signup and view all the answers

    According to the National Osteoporosis Foundation guidelines, who is recommended to receive pharmacotherapy for osteoporosis?

    <p>Postmenopausal women and men over 50 with specific fracture risks</p> Signup and view all the answers

    Which of the following medications is classified as an anabolic therapy for osteoporosis?

    <p>Teriparatide</p> Signup and view all the answers

    What is a major characteristic of anti-resorptive medications in osteoporosis treatment?

    <p>They inhibit osteoclast activity</p> Signup and view all the answers

    In assessing the case of a 54-year-old female with a femoral neck T-score of -1.1, how is her bone density categorized?

    <p>Osteopenia</p> Signup and view all the answers

    Which medication targets an osteocyte-derived protein in the treatment of osteoporosis?

    <p>Romosozumab</p> Signup and view all the answers

    What is the primary concern for individuals with a T-score between -1 and -2.5 and a 10-year probability of a hip fracture of ≥3%?

    <p>They may require pharmacotherapy</p> Signup and view all the answers

    Study Notes

    Bone Resorption and Therapy

    • After withdrawing teriparatide, "rebound" bone resorption may occur.
    • Switching to an antiresorptive therapy like alendronate or denosumab is generally recommended.

    Case #4: Osteoporosis

    • 88-year-old African American female
    • Height: 168 cm (about 5'6"), Weight: 53 kg (about 115 lbs)
    • Previous fracture: yes, Parental hip fracture: yes, Current smoker: no, Glucocorticoid use: no, Rheumatoid Arthritis: no, Second Opinion: no, Excess alcohol: no.
    • Femoral neck T-score: -4.0
    • This indicates osteoporosis, and pharmacotherapy may be justified.

    Romosozumab

    • Monoclonal antibody that targets Sclerostin, reducing Wnt pathway inhibition.
    • Primarily increases bone formation and has some effect on decreasing bone resorption.
    • Contraindicated in patients with a history of myocardial infarction within the preceding year.
    • Costly and cannot be used for longer than 1 year.
    • Should be followed by an anti-resorptive therapy after discontinuation.

    Major Osteoporosis Therapies Summary

    • National Osteoporosis Foundation (NOF) provides guidelines for initiating pharmacotherapy.
    • Calcium and Vitamin D supplementation is recommended for patients with insufficient dietary intake.
    • American Association of Clinical Endocrinologists (AACE) recommends bisphosphonates (like alendronate) and denosumab as first-line therapies, reserving teriparatide for patients with very low BMD or those unresponsive to bisphosphonates.
    • Bisphosphonates (e.g., alendronate) and denosumab are anti-resorptive therapies.
      • Bisphosphonates selectively incorporate into bone matrix, inhibiting osteoclast activity.
      • Denosumab is a neutralizing antibody targeting RANKL, reducing osteoclastogenesis.
      • Bisphosphonate therapy requires a drug holiday due to the risk of atypical femoral fractures and osteonecrosis of the jaw (ONJ). Denosumab does not have a similar recommendation.
    • Teriparatide, abaloparatide, and romosozumab increase bone formation by activating osteoblasts. Romosozumab also inhibits osteoclasts.

    Anabolic Therapies

    • Teriparatide, abaloparatide, and romosozumab are FDA-approved anabolic therapies in the U.S.A.
      • Teriparatide and abaloparatide are administered daily via subcutaneous injection (SQ).
      • Romosozumab is delivered via monthly SQ injection.
    • AACE recommends teriparatide for patients with very low BMD (or high fracture risk) or when bisphosphonates have failed.
    • Further advice on abaloparatide and romosozumab is expected in the future.

    Teriparatide

    • Active form of Parathyroid Hormone (PTH).
    • Sustained PTH signaling leads to bone loss (e.g., primary hyperparathyroidism) by promoting osteoclastogenesis.
    • Intermittent PTH (iPTH) signaling preferentially activates osteoblasts to increase bone formation.

    Case #3: Osteopenia

    • 54-year-old Asian female
    • Height: 165 cm (about 5'5"), Weight: 59 kg (about 130 lbs)
    • Previous fracture: yes, Parental hip fracture: yes, Current smoker: no, Glucocorticoid use: yes, Rheumatoid Arthritis: yes, Second Opinion: no, Excess alcohol: no.
    • Femoral neck T-score: -1.1
    • This indicates osteopenia.
    • Pharmacotherapy may be justified depending on the patient's individual risk factors.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    Description

    This quiz covers key information about osteoporosis, including case studies and treatment strategies like teriparatide, alendronate, and romosozumab. Assess your understanding of bone resorption, therapy recommendations, and patient management approaches for osteoporosis. Gain insights into the implications of treatment choices based on patient history and condition.

    More Like This

    Use Quizgecko on...
    Browser
    Browser